메뉴 건너뛰기




Volumn 386, Issue 6, 2006, Pages 1657-1664

Development of a competitive ELISA for the quantification of F5 conjugate in HER2-targeted STEALTH immunoliposome doxorubicin in plasma samples

Author keywords

Assay development; Competitive ELISA; F5 conjugate (F5CG); HER2 receptor; Targeted immunoliposomal formulation

Indexed keywords

ANTIBODIES; BIOASSAY; CONCENTRATION (PROCESS); LIPIDS; MONOMERS; TUMORS;

EID: 33751183263     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-006-0733-6     Document Type: Article
Times cited : (5)

References (21)
  • 9
    • 1642283702 scopus 로고
    • Tyle P, Ram BP (ed) Marcel Dekker, New York
    • Tyle P, Ram BP (ed) (1990) Targeted therapeutic systems. Marcel Dekker, New York
    • (1990) Targeted Therapeutic Systems
  • 10
    • 33751180915 scopus 로고    scopus 로고
    • Francis GE, Delgado C (ed) Humana, Totowa, NJ
    • Francis GE, Delgado C (ed) (2000) Drug targeting. Humana, Totowa, NJ
    • (2000) Drug Targeting
  • 17
    • 0003484310 scopus 로고    scopus 로고
    • Center for Drug Evaluation and Research (CDER), and Center for Veterinary Medicine (CVM), FDA
    • Guidance for industry, bioanalytical method validation (2001) Center for Drug Evaluation and Research (CDER), and Center for Veterinary Medicine (CVM), FDA
    • (2001) Guidance for Industry, Bioanalytical Method Validation
  • 21
    • 0003844920 scopus 로고
    • Crowther JR (ed) Humana, Totowa, NJ
    • Crowther JR (1995) (ed) ELISA: theory and practice. Humana, Totowa, NJ
    • (1995) ELISA: Theory and Practice


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.